 SAN DIEGO , June 8, 2022 PRNewswire -- Halozyme Therapeutics, Inc. NASDAQ: HALO Halozyme today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to present and host investor meetings at the Goldman Sachs 43rd Annual Global Healthcare Conference being held in Rancho Palos Verdes, CA on June 14-16, 2022. Details of the presentation are as follow: Event: Goldman Sachs 43rd Annual Global Healthcare Conference Format: Fireside Chat and 1x1 Meetings Presentation Date: Wednesday, June 15, 2022 Presentation Time: 8:00 a.m. 